Ironwood Pharmaceuticals to Participate in the 2024 Wells Fargo Healthcare Conference
30 8월 2024 - 5:01AM
Business Wire
Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) will participate
in a fireside chat at the 2024 Wells Fargo Healthcare Conference on
Thursday, September 5, 2024 at 2:15 p.m. ET at the Encore Boston
Harbor.
A live webcast of Ironwood’s fireside chat will be accessible
through the Investors section of the company’s website at
www.ironwoodpharma.com. A replay of the webcast will be available
on Ironwood’s website for 1 year following the conference.
About Ironwood Pharmaceuticals
Ironwood Pharmaceuticals (Nasdaq: IRWD), an S&P SmallCap
600® company, is a leading gastrointestinal (GI) healthcare company
on a mission to advance the treatment of GI diseases and redefine
the standard of care for GI patients. We are pioneers in the
development of LINZESS® (linaclotide), the U.S. branded
prescription market leader for adults with irritable bowel syndrome
with constipation (IBS-C) or chronic idiopathic constipation (CIC).
LINZESS is also approved for the treatment of functional
constipation in pediatric patients ages 6-17 years-old. Ironwood is
also advancing apraglutide, a next-generation, long-acting
synthetic GLP-2 analog being developed for rare gastrointestinal
diseases, including short bowel syndrome with intestinal failure
(SBS-IF), as well as several earlier stage assets. Building upon
our history of GI innovation, we keep patients at the heart of our
R&D and commercialization efforts to reduce the burden of GI
diseases and address significant unmet needs.
Founded in 1998, Ironwood Pharmaceuticals is headquartered in
Boston, Massachusetts, with a site in Basel, Switzerland.
We routinely post information that may be important to investors
on our website at www.ironwoodpharma.com. In addition, follow us on
X and on LinkedIn.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240829395243/en/
Investors:
Greg Martini, 617-374-5230 gmartini@ironwoodpharma.com
Matt Roache, 617-621-8395 mroache@ironwoodpharma.com
Media:
Beth Calitri, 978-417-2031 bcalitri@ironwoodpharma.com
Ironwood Pharmaceuticals (NASDAQ:IRWD)
과거 데이터 주식 차트
부터 11월(11) 2024 으로 12월(12) 2024
Ironwood Pharmaceuticals (NASDAQ:IRWD)
과거 데이터 주식 차트
부터 12월(12) 2023 으로 12월(12) 2024
